Annual Book Value
-$151.60 M
-$164.20 M-1303.21%
31 December 2023
Summary:
Revance Therapeutics annual book value is currently -$151.60 million, with the most recent change of -$164.20 million (-1303.21%) on 31 December 2023. During the last 3 years, it has fallen by -$220.07 million (-321.41%). RVNC annual book value is now -140.50% below its all-time high of $374.29 million, reached on 31 December 2020.RVNC Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
-$163.03 M
-$33.29 M-25.66%
30 September 2024
Summary:
Revance Therapeutics quarterly book value is currently -$163.03 million, with the most recent change of -$33.29 million (-25.66%) on 30 September 2024. Over the past year, it has dropped by -$11.43 million (-7.54%). RVNC quarterly book value is now -143.56% below its all-time high of $374.29 million, reached on 31 December 2020.RVNC Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -7.5% |
| 3 y3 years | -321.4% | -338.1% |
| 5 y5 years | -167.2% | -172.3% |
RVNC Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -321.4% | at low | -211.9% | at low |
| 5 y | 5 years | -140.5% | at low | -143.6% | at low |
| alltime | all time | -140.5% | +30.1% | -143.6% | +24.8% |
Revance Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$163.03 M(+25.7%) |
| June 2024 | - | -$129.74 M(+31.5%) |
| Mar 2024 | - | -$98.67 M(-34.9%) |
| Dec 2023 | -$151.60 M(-1303.2%) | -$151.60 M(+42.8%) |
| Sept 2023 | - | -$106.20 M(-496.5%) |
| June 2023 | - | $26.79 M(-200.4%) |
| Mar 2023 | - | -$26.67 M(-311.7%) |
| Dec 2022 | $12.60 M(-81.6%) | $12.60 M(-91.4%) |
| Sept 2022 | - | $145.71 M(-5638.3%) |
| June 2022 | - | -$2.63 M(-110.3%) |
| Mar 2022 | - | $25.54 M(-62.7%) |
| Dec 2021 | $68.47 M(-81.7%) | $68.47 M(-43.0%) |
| Sept 2021 | - | $120.16 M(-35.5%) |
| June 2021 | - | $186.24 M(-23.8%) |
| Mar 2021 | - | $244.25 M(-34.7%) |
| Dec 2020 | $374.29 M(+66.0%) | $374.29 M(+0.4%) |
| Sept 2020 | - | $372.85 M(+45.8%) |
| June 2020 | - | $255.72 M(-17.1%) |
| Mar 2020 | - | $308.38 M(+36.8%) |
| Dec 2019 | $225.49 M(+54.8%) | $225.49 M(+49.1%) |
| Sept 2019 | - | $151.28 M(-19.8%) |
| June 2019 | - | $188.54 M(-14.7%) |
| Mar 2019 | - | $221.10 M(+51.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $145.62 M(-45.8%) | $145.62 M(-20.0%) |
| Sept 2018 | - | $182.10 M(-13.2%) |
| June 2018 | - | $209.85 M(-11.3%) |
| Mar 2018 | - | $236.64 M(-12.0%) |
| Dec 2017 | $268.85 M(+51.8%) | $268.85 M(+89.3%) |
| Sept 2017 | - | $142.06 M(-10.9%) |
| June 2017 | - | $159.41 M(-10.8%) |
| Mar 2017 | - | $178.67 M(+0.9%) |
| Dec 2016 | $177.07 M(-30.1%) | $177.07 M(-11.8%) |
| Sept 2016 | - | $200.72 M(-7.0%) |
| June 2016 | - | $215.78 M(-8.9%) |
| Mar 2016 | - | $236.85 M(-6.5%) |
| Dec 2015 | $253.25 M(+43.6%) | $253.25 M(+77.9%) |
| Sept 2015 | - | $142.36 M(-4.4%) |
| June 2015 | - | $148.84 M(-8.9%) |
| Mar 2015 | - | $163.46 M(-7.3%) |
| Dec 2014 | $176.37 M(-211.9%) | $176.37 M(-6.1%) |
| Sept 2014 | - | $187.91 M(-5.3%) |
| June 2014 | - | $198.51 M(+152.3%) |
| Mar 2014 | - | $78.69 M(-149.9%) |
| Dec 2013 | -$157.55 M(-27.3%) | -$157.55 M(+608.3%) |
| Sept 2013 | - | -$22.24 M(-89.7%) |
| Dec 2012 | -$216.73 M(+39.4%) | -$216.73 M |
| Dec 2011 | -$155.48 M | - |
FAQ
- What is Revance Therapeutics annual book value?
- What is the all time high annual book value for Revance Therapeutics?
- What is Revance Therapeutics quarterly book value?
- What is the all time high quarterly book value for Revance Therapeutics?
- What is Revance Therapeutics quarterly book value year-on-year change?
What is Revance Therapeutics annual book value?
The current annual book value of RVNC is -$151.60 M
What is the all time high annual book value for Revance Therapeutics?
Revance Therapeutics all-time high annual book value is $374.29 M
What is Revance Therapeutics quarterly book value?
The current quarterly book value of RVNC is -$163.03 M
What is the all time high quarterly book value for Revance Therapeutics?
Revance Therapeutics all-time high quarterly book value is $374.29 M
What is Revance Therapeutics quarterly book value year-on-year change?
Over the past year, RVNC quarterly book value has changed by -$11.43 M (-7.54%)